Capivasertib, sold under the brand name Truqap, is an anti-cancer medication used to treat hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer. Reference standards of Capivasertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
No Data Found
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
